RNAseq analysis obtained from on-purpose tumor biopsies of patients in the MATCH-R trial allows the identification of potential mechanisms of acquired resistance to PD(L)1 therapies

This article has no abstract
Epistemonikos ID: e2493dce1c980e0a793b3a210ee13ff94b7a7781
First added on: Feb 08, 2025